Yufei Bo

959 total citations · 4 hit papers
7 papers, 397 citations indexed

About

Yufei Bo is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Yufei Bo has authored 7 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Yufei Bo's work include Cancer Immunotherapy and Biomarkers (3 papers), Single-cell and spatial transcriptomics (2 papers) and IL-33, ST2, and ILC Pathways (2 papers). Yufei Bo is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Single-cell and spatial transcriptomics (2 papers) and IL-33, ST2, and ILC Pathways (2 papers). Yufei Bo collaborates with scholars based in China. Yufei Bo's co-authors include Wenhong Hou, Dongfang Wang, Jianan Li, Zemin Zhang, Linnan Zhu, Shishang Qin, Jinhu Li, Lu Qi, Jirun Peng and Kezhuo Yu and has published in prestigious journals such as Cell, Cancer Cell and Cell Reports.

In The Last Decade

Yufei Bo

6 papers receiving 395 citations

Hit Papers

A pan-cancer single-cell panorama of human natural killer... 2023 2026 2024 2025 2023 2024 2024 2024 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yufei Bo China 4 195 193 141 76 61 7 397
Guodong Deng China 12 175 0.9× 122 0.6× 162 1.1× 79 1.0× 73 1.2× 30 392
Chen Hao Lo United States 10 167 0.9× 132 0.7× 148 1.0× 76 1.0× 77 1.3× 17 366
Fabio Scirocchi Italy 10 193 1.0× 155 0.8× 130 0.9× 87 1.1× 83 1.4× 15 395
Steven M.J. Bradbury United Kingdom 3 199 1.0× 112 0.6× 164 1.2× 60 0.8× 38 0.6× 3 335
Qinglin Fei China 8 210 1.1× 185 1.0× 134 1.0× 52 0.7× 40 0.7× 16 362
Changchang Lu China 9 260 1.3× 247 1.3× 131 0.9× 74 1.0× 58 1.0× 20 448
Kunpeng Lv China 14 271 1.4× 274 1.4× 142 1.0× 88 1.2× 109 1.8× 19 484
Wenhong Hou China 5 132 0.7× 140 0.7× 134 1.0× 64 0.8× 37 0.6× 5 330
Katrin Almstedt Germany 12 270 1.4× 95 0.5× 125 0.9× 119 1.6× 95 1.6× 33 403
Jian Yuan Goh Singapore 8 118 0.6× 120 0.6× 164 1.2× 117 1.5× 56 0.9× 14 340

Countries citing papers authored by Yufei Bo

Since Specialization
Citations

This map shows the geographic impact of Yufei Bo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yufei Bo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yufei Bo more than expected).

Fields of papers citing papers by Yufei Bo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yufei Bo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yufei Bo. The network helps show where Yufei Bo may publish in the future.

Co-authorship network of co-authors of Yufei Bo

This figure shows the co-authorship network connecting the top 25 collaborators of Yufei Bo. A scholar is included among the top collaborators of Yufei Bo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yufei Bo. Yufei Bo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Si, Wen, Sijin Cheng, Haiyin He, et al.. (2025). SARDH in the 1-C metabolism sculpts the T-cell fate and serves as a potential cancer therapeutic target. Cellular and Molecular Immunology. 22(11). 1363–1378.
2.
Li, Xiangjie, Xiaojing Chu, Wenbin Xu, et al.. (2025). Integrated spatial transcriptomic profiling to dissect the cellular characteristics of tumor-associated tertiary lymphoid structures. Cell Reports. 44(9). 116250–116250. 1 indexed citations
3.
Zhao, Shuyun, Shuai Hao, Xinran Chen, et al.. (2024). mTOR/miR-142-3p/PRAS40 signaling cascade is critical for tuberous sclerosis complex-associated renal cystogenesis. Cellular & Molecular Biology Letters. 29(1). 125–125. 1 indexed citations
4.
Yu, Yang, Xueyan Chen, Yaojun Zhang, et al.. (2024). Pan-cancer single-cell dissection reveals phenotypically distinct B cell subtypes. Cell. 187(17). 4790–4811.e22. 63 indexed citations breakdown →
5.
Chen, Yuqing, Dongfang Wang, Yingjie Li, et al.. (2024). Spatiotemporal single-cell analysis decodes cellular dynamics underlying different responses to immunotherapy in colorectal cancer. Cancer Cell. 42(7). 1268–1285.e7. 62 indexed citations breakdown →
6.
Li, Jianan, Huilan Liu, Yufei Bo, et al.. (2024). Cross-tissue human fibroblast atlas reveals myofibroblast subtypes with distinct roles in immune modulation. Cancer Cell. 42(10). 1764–1783.e10. 83 indexed citations breakdown →
7.
Tang, Fei, Jinhu Li, Lu Qi, et al.. (2023). A pan-cancer single-cell panorama of human natural killer cells. Cell. 186(19). 4235–4251.e20. 187 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026